Nootropic peptides

Russian-origin synthetic peptide. Anxiolytic and cognitive support without the sedation profile of benzos.

Delta Sleep-Inducing Peptide. A brain-origin peptide aimed at sleep architecture. Limited human data, mixed user reports.

For alertness and focus. A Russian-origin nootropic peptide on the alert/focus end of the spectrum that pairs with Selank for a balanced cognitive stack.

The 'bonding hormone' you make naturally. Synthetic oxytocin is FDA-approved for labor; off-label use covers social, anxiety, and intimacy contexts.

A brain compound aimed at building new connections between neurons. An angiotensin IV analog with strong synaptogenic effect in animal models, often-cited as 'BDNF on steroids.' Very limited human data.

A brain-recovery drug used abroad for stroke, head injury, and Alzheimer's. A porcine brain-derived peptide complex used clinically in 50+ countries (Russia, China, Mexico, EU) for stroke recovery, TBI, and Alzheimer's. It's a mixture of low-molecular-weight peptides, not a single compound.

A compound studied to protect the brain cells lost in Parkinson's. An 11-amino-acid peptide from the proGDNF domain (the prodomain of glial cell line-derived neurotrophic factor, GDNF), also called Dopamine Neuron Stimulating Peptide-11. Pre-clinical neuroprotection for dopaminergic neurons in Parkinson's models.

Studied for memory and learning in animal models. It's an FG-loop peptide modeled on the FG-loop region of NCAM (neural cell adhesion molecule).

Synthetic ciliary neurotrophic factor (CNTF)-mimetic peptide. Targets neurogenesis. Pre-clinical / early research compound.

Synthetic peptide derived from spadin. TREK-1 channel inhibitor with rapid antidepressant effects in animal models. Pre-clinical.